Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-30

FDA Approved: DHIVY — Supplemental Application (Avion Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a supplemental application for DHIVY (carbidopa-levodopa) from Avion Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DHIVY (Carbidopa/Levodopa)

Snippet

SUPPL AP for DHIVY (CARBIDOPA LEVODOPA)